Pay in 4 interest-free payments of $7.08 Learn more
Ships within 48 hours · Estimated delivery Sep 22 - Sep 27
The open-label extension treatment period starts at the first dose after Week 48 and ends at the last visit on or prior to Week 72
Any of these scenarios can push temperatures well above the stability threshold and render the medication useless, or worse, potentially harmful
IUPHAR/BPS Guide to PHARMACOLOGY
123 Rivus Pharmaceuticals announces positive topline results from phase 2 M-ACCEL trial of HU-6 showing significant reductions in liver fat in patients with MASH(2025)
Obesity is a major risk factor for many chronic conditions like type 2 diabetes and cardiovascular diseases
US$ 24.64
US$ 28.32
US$ 28.34
US$ 20.30
US$ 26.54
US$ 22.06
US$ 22.30
US$ 23.38
